| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT06249555 VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's… |
Enrollment closed, study ongoing |
| 2026-08-15 | NCT06249555 VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's… |
date change Primary completion pushed: 2026-06 -> 2026-09 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06257706 | VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease | Moderately to Severely Active Crohn's Disease | Recruiting |
| NCT06997965 | Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With… | Crohn Disease | Recruiting |
| NCT04259138 | Determination of the Optimal Treatment Target in Ulcerative Colitis | Colitis, Ulcerative | Active, Not Recruiting |
| NCT03261206 | Stopping Aminosalicylate Therapy in Inactive Crohn's Disease | Crohn Disease | Active, Not Recruiting |
| Not specified | |||
| NCT06670638 | Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical… | Crohns Disease | Recruiting |
| NCT07363044 | A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus… | Crohn Disease (CD) | Recruiting |
| NCT03765450 | Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in… | Ulcerative Colitis | Active, Not Recruiting |
| NCT06249555 | VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's… | Crohn's Disease | Active, Not Recruiting |